Abstract
The potential value of 123I-heptadecanoic acid (123I-HoA) in myocardial scintigraphy has recently been assessed in patients with acute myocardial infarction (AMI) by studying regional myocardial metabolism (Van der Wall et al. 1981 a). To determine the metabolic behavior of 123I-HoA in patients with stable angina pectoris (AP) as well, 30 patients with AP were included in this study: 18 patients were exercised and 12 patients were studied at rest.
Regional myocardial metabolism was evaluated by generating background subtracted time-activity curves, acquired by external detection over normally perfused and ischemic regions during a 30-min period after intravenous injection of 123I-HoA. Following monoexponential curve-fitting, clearance rates were measured representing turnover rate (T1/2) of 123I-HoA.
The exercise group showed prolonged T1/2 values of 46.7±7.1 min (mean±SD) in ischemic regions and 28.7±3.6 min in normally perfused regions. The group at rest did not reveal any scintigraphic abnormalities and showed normal T1/2 values in all myocardial regions (29.1±4.7 min).
Our observations of prolonged turnover rates in ischemic areas differ from the results of our recent study in patients with AMI, which demonstrated fast turnover rates in infarcted tissue. These data imply that 123I-HoA permits the study of myocardial metabolism in patients with AP and the discrimination of normally perfused, reversibly ischemic (AP) and irreversibly ischemic (AMI) myocardium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bruce RH (1971) Exercise testing of patients with coronary heart disease. Ann Clin Res 3:323–332
Carlsten A, Hallgren B, Jagenburg R, Svanborg A, Werkö L (1961) Myocardial metabolism of glucose, lactid acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads. Scand J Clin Lab Invest 13:418–428
Feinendegen LE (1980) Metabolic substrates in the heart, free fatty acid metabolism. In: Radionuclides in heart disease. Microcirculation working gruop; Oxford (abstract)
Freundlieb C, Höck A, Vyska K, Feinendegen LE, Machulla HJ, Stöcklin G (1978) Anwendung von 123I-markierten langkettige Fettsäuren zum Studium des Herzmuskel-Stoffwechsels. Radioakt Isot Klin Forsch 13:265–272
Goldstein RA, Klein MS, Welch MJ, Sobel BE (1980) External assessment of myocardial metabolism with C-11 palmitate in vivo. J Nucl Med 21:342–348
Gould KL, Lipscomb K, Hamilton GW (1974) Physiologic basis for assessing critical coronary stenosis. Am J Cardiol 33:87–94
Hildner FJ (1977) Myocardial anergetics. In: Serafini AN (ed) Nuclear cardiology: principles and methods. Plenum Medical Book Company, New York and London, p 72
Huckell VF, Lyster DM, Morrison RT (1980) The potential role of 123-Iodine-hexadecenoic acid in assessing normal and abnormal myocardial metabolism. J Nucl Med 21:P57
Klassen GA (1972) Constant infusion of indicators to measure flow and volume in the left coronary system in man. In: Maseri A (ed) Myocardial blood flow in man. Methods and significance in coronary disease. Minerva Medica, Turin, pp 164–173
Machulla HJ, Stöcklin G, Kupfernagel C, Freundlieb C, Höck A, Vyska K, Feinendegen LE (1978) Comparative evaluation of fatty acids labeled with C-11, Cl-34 m, Br-77 and I-123 for metabolic studies of the myocardium: Concise communication. J Nucl Med 19:298–302
Maseri A (1975) Myocardial blood flow in ischemia, and its measurement. In: Oliver MF (ed) Modern trends in cardiology, Butterworths, London and Boston, pp 115–153
Neely JR, Rovetto MJ, Oram JF (1972) Myocardial utilization of carbohydrate and lipids. Progr Cardiovasc Dis 15:289–329
Opie LH (1968) Metabolism of the heart in health and disease. PartI. Am Heart J 70:685–698
Opie LH (1976) Effects of regional ischemia on metabolism of glucose and fatty acids. Circ Res Suppl 1:52–68
Ritchie JL, Trobaugh GB, Hamilton GW, Gould KL, Narahara KA, Murray JA, Williams DL (1977) Myocardial imaging with Thallium-201 at rest and during exercise. Circulation 56:66–72
Sobel BE (1979) Non-invasive regional assessment of myocardium with positron-emitting radionuclides. Adv Cardiol 26:15–29
Vyska K, Höck A, Profant M, Feinendegen LE, Machulla HJ, Stöcklin G (1979) Myocardial imaging and measurement of myocardial fatty acid metabolism using ω-123I-heptadecanoic acid (abstract). J Nucl Med 20:650
Van der Wall EE, Heidendal GAK, Den Hollander W, Westera G, Roos JP (1980) 123I labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. Eur J Nucl Med 5:401–405
Van der Wall EE, Den Hollander W, Heidendal GAK, Westera G, Majid PA, Roos JP (1981 a) Dynamic myocardial scintigraphy with 123I labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med 6:
Van der Wall EE, Westera G, Den Hollander W, Visser FC (1981 b) External detection of regional myocardial metabolism with radioiodinated hexadecenoic acid in the dog heart. Eur J Nucl Med 6:147–151
Weiss ES, Hoffman EJ, Phelps ME, Welch MJ, Henry PD, Ter Pogossian MM, Sobel BE (1976) External detection and visualisation of myocardial ischemia with 11C-substrates in vitro and in vivo. Circ Res 39:24–32
Westera G, Van der Wall EE, Heidendal GAK, Van den Bos GC (1980) A comparison between terminally radioiodinated hexadecenoic acid and Thallium-chloride in the dog heart. Implications for the use of I-HA for myocardial imaging. Eur J Nucl Med 5:339–343
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Wall, E.E., Heidendal, G.A.K., den Hollander, W. et al. Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 6, 391–396 (1981). https://doi.org/10.1007/BF00266428
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00266428